MSc or PhD in Statistics, Biostatistics, or a related quantitative field.
3+ years of clinical trial statistics experience (PhD) or 4+ years (MSc) in pharma, biotech, or CRO settings.
Familiarity with ICH guidelines, GCP, and FDA/EMA regulatory requirements.
Strong understanding of statistical principles for clinical trial design and analysis.
Proficient in SAS and/or R; familiarity with CDISC standards.
Responsibilities
Contribute to early phase trial design using standard and adaptive methods.
Draft and review protocols, SAPs, and CRFs to align with early development goals.
Perform statistical analyses per SAPs, addressing non-traditional endpoints and data anomalies.
Collaborate with study teams to meet accelerated deliverables in early phase trials.
Summarize findings clearly to inform early go/no-go decisions and subsequent phase designs.
Contribute to clinical study reports and regulatory submissions for INDs and FDA meetings.
Apply judgment to solve moderately complex statistical issues while seeking guidance when needed.
Benefits
Comprehensive health insurance options.
Retirement savings plan with company match.
Paid time off and holidays.
Professional development opportunities.
Flexible work arrangements.
Full Job Description
The Opportunity:
The Early Development Statistician helps shape the early clinical narrative by ensuring data are robust, interpretable, and aligned with the evolving development strategy. Key responsibilities include:
You contribute to early phase trial design under guidance, leveraging standard and adaptive methods for small samples and exploratory objectives, for example dose escalation models and Bayesian approaches
You draft and review protocols, SAPs, and CRFs using established templates and examples, ensuring alignment with early development goals such as pharmacokinetics, pharmacodynamics, and early efficacy signals
You perform or support statistical analyses per SAPs, often with non traditional endpoints or biomarkers, and proactively flag data anomalies or design related challenges given smaller datasets and less mature endpoints
You collaborate with study teams to meet deliverables on accelerated timelines, adhering to evolving processes common in early phase trials
You summarize findings clearly with support, translating complex outputs into concise insights that inform early go no go decisions or subsequent phase designs
You contribute to clinical study reports and regulatory submissions, supporting documentation for INDs, EMA scientific advice, and FDA pre IND meetings, using appropriate templates
You apply judgment to solve moderately complex statistical or data issues, balancing rigor with the flexibility needed in early phase development, and seek guidance when facing novel or ambiguous situations
You adhere to functional standards and participate in peer review and mentoring to uphold quality while building expertise in early phase methodology and regulatory expectations
You work under general supervision and apply independent judgment to interpret guidance, prioritize responsibilities, and make decisions in situations that require contextual understanding
Who You Are:
You hold an MSc or PhD in Statistics, Biostatistics, or a closely related quantitative field.
You bring at least 3 years of relevant experience (with a PhD) or 4 years of experience (with an MSc) in clinical trial statistics within pharmaceutical, biotech, or CRO settings.
You are familiar with ICH guidelines, GCP, and regulatory requirements such as FDA and EMA
You have a strong understanding of statistical principles and methodologies relevant to clinical trial design and analysis
You are proficient in SAS and or R and familiar with CDISC standards
Preferred:
Experience working in cross-functional global study teams, including Clinical Pharmacology, Translational Medicine, and Early Clinical Development
Effective communication skills with the ability to translate complex, often exploratory or model-based statistical concepts for non-statistical audiences, including clinicians and early decision-makers
Basic understanding of the multiple phases of drug development, with a strong emphasis on early-phase (Phase I/II) design and analysis, including first-in-human, SAD/MAD, and proof-of-concept studies
Experience within a matrixed early development environment, including providing statistical guidance in fast-paced, high-uncertainty settings
Familiarity with innovative design methods (e.g., Bayesian designs, model-informed drug development) and regulatory expectations for exploratory endpoints
Agility and comfort working with incomplete or evolving data and pivoting approaches based on emerging results in early clinical trials
Relocation benefits are not available for this posting
The expected salary range for this position based on the primary location of California is $124,800 - $231,800. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance. This position also qualifies for the benefits detailed at the link provided below.
About Roche
Roche Holding AG is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has bearer shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the largest pharmaceutical company in the world, and the leading provider of cancer treatments globally. The company also produces a range of diagnostic tests for medical professionals and patients. Roche was one of the first companies to bring targeted treatments to patients. In 2019, Roche had over 100,000 employees worldwide, and generated revenue of CHF 61.5 billion.